Key opinion leaders explore the diagnosis, management, and treatment of attention deficit hyperactivity disorder (ADHD) in the adult population and share key insights on the evolving treatment landscape.
EP. 1: Overview of Attention-Deficit/Hyperactivity Disorders (ADHD)
David W. Goodman, MD; Greg Mattingly, MD; and Birgit H. Amann, MD, provide an overview of ADHD, including its pathophysiology as well as its prevalence in the pediatric and adult populations.
EP. 2: Diagnosis, Continuation, and Remission of ADHD in Adulthood
Drs David W. Goodman, Rakesh Jain, Greg Mattingly, and Theresa R. Cerulli, discuss continuation of ADHD from childhood as well as data on remission of ADHD in adulthood.
EP. 3: Clinical Burden of Adult ADHD
Birgit H. Amann, MD; Rakesh Jain, MD, MPH; David W. Goodman, MD; Greg Mattingly, MD; and Theresa R. Cerulli, MD, share insight on the impact of ADHD on quality of life in adult patients.
EP. 4: Unmet Needs in ADHD
Experts in the management of ADHD comment on unmet needs in disease management in the areas of diagnosis, treatment, and coverage of symptoms.
EP. 5: Approaching the Diagnosis of ADHD
Drs Birgit H. Amann, David W. Goodman, and Greg Mattingly discuss signs and symptoms that may prompt testing for adult ADHD and share their considerations for approaching diagnosis.
EP. 6: Role of Pediatric ADHD Guidelines in Diagnosis of ADHD
Greg Mattingly, MD; David W. Goodman, MD; Birgit H. Amann, MD; and Theresa R. Cerulli, MD, evaluate the role of pediatric ADHD guidelines and common misconceptions in the diagnosis and treatment of ADHD.
EP. 7: Goals of ADHD Treatment
Birgit H. Amann, MD, and Greg Mattingly, MD, review patient and provider goals of treatment and provide insight on evaluating response to treatment for ADHD.
EP. 8: Impact of Telehealth on the Management of Adult ADHD
Experts in ADHD discuss the benefits and challenges of telehealth on the diagnosis and management of adult ADHD.
EP. 9: Treatment Selection for Adult ADHD
Rakesh Jain, MD, MPH, leads a discussion on factors that guide treatment selection for adult patients with ADHD.
EP. 10: Role of Integrative Treatment in Adult ADHD
Rakesh Jain, MD, MPH, explores the role of an integrative treatment approach in regard to nonpharmacological treatment for the management of adult ADHD.
EP. 11: Safety and Efficacy of Medications for ADHD Management
Dr David W. Goodman reviews the efficacy and tolerability of different classes of medications for the management of ADHD.
EP. 12: Medication Challenges and Risks for Adult ADHD Treatment
Birgit H. Amann, MD; Rakesh Jain, MD, MPH; Theresa R. Cerulli, MD; and David W. Goodman, MD, share unmet needs and risks in the treatment of adult ADHD.
EP. 13: Clinical Profile of Viloxazine in the Treatment of ADHD
Greg Mattingly, MD, and David W. Goodman, MD, discuss the recent approval of viloxazine in children and its clinical profile in the pediatric and adult populations in ADHD.
EP. 14: Using Viloxazine in Clinical Practice for the Management of ADHD
Key opinion leaders in the management of ADHD comment on where they anticipate using viloxazine and other nonstimulants in the ADHD treatment landscape.
EP. 15: Managing Patients with ADHD on Viloxazine
Birgit H. Amann, MD, and Greg Mattingly, MD, share strategies for mitigating adverse events with viloxazine in ADHD and its effect on metabolism of drugs.
EP. 16: Role of Viloxazine in Adult ADHD Treatment
David W. Goodman, MD, leads a discussion on the use of viloxazine for the treatment of adults with ADHD.
EP. 17: Novel Agents for the Management of Pediatric and Adult ADHD
Drs Rakesh Jain, Greg Mattingly, David W. Goodman, Birgit H. Amann, and Theresa R. Cerulli, discuss emerging agents in the pipeline for the management of pediatric and adult ADHD.
Gastroenterology Year in Review: 2024
Dermatology Year in Review: 2024
2024 Brings Change, New Hope for Nonhormonal Management of Menopause
Hepatology Year in Review: 2024